4//SEC Filing
O'Brien Stephanie Monaghan 4
Accession 0001127602-20-000705
CIK 0001492422other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:31 PM ET
Size
5.1 KB
Accession
0001127602-20-000705
Insider Transaction Report
Form 4
O'Brien Stephanie Monaghan
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-01$30.62/sh+27,600$845,112→ 27,600 totalExercise: $30.62Exp: 2029-12-31→ Common Stock (27,600 underlying)
Footnotes (1)
- [F1]This option was granted 01/01/2020. The option vests quarterly over 1 year on the last day of each quarter from grant date.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720907
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:31 PM ET
- Size
- 5.1 KB